Enteric-coated mycophenolate sodium given in combination with tacrolimus has a lower incidence of serious infections in Asian renal-transplant recipients compared with mycophenolate mofetil.

about

Enteric-coated mycophenolate sodium given in combination with tacrolimus has a lower incidence of serious infections in Asian renal-transplant recipients compared with mycophenolate mofetil.

Item

http://www.wikidata.org/entity/Q41107370

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Enteric-coated mycophenolate s ...... ed with mycophenolate mofetil.

@en

type

Item

label

Enteric-coated mycophenolate s ...... ed with mycophenolate mofetil.

@en

prefLabel

Enteric-coated mycophenolate s ...... ed with mycophenolate mofetil.

@en

P1476

Enteric-coated mycophenolate s ...... ed with mycophenolate mofetil.

@en

P2093

J J Feng

http://www.w3.org/2001/XMLSchema#string

J Tian

http://www.w3.org/2001/XMLSchema#string

L M Bow

http://www.w3.org/2001/XMLSchema#string

L W Zhang

http://www.w3.org/2001/XMLSchema#string

P Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management.

Improved gastrointestinal symptoms and quality of life after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients receiving tacrolimus.

Comparing outcomes associated with dose manipulations of enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients.

Enteric-coated mycophenolate sodium immunosuppression in renal transplant patients: efficacy and dosing.

Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil.

Conversion to enteric-coated mycophenolate sodium from various doses of mycophenolate mofetil: results of a prospective international multicenter trial in maintenance renal transplant patients receiving cyclosporine.

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant patients: preliminary results from the myfortic prospective multicenter study.

Lower incidence of chronic allograft nephropathy at 1 year post-transplantation in patients treated with mycophenolate mofetil.

Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients.

Conversion to enteric-coated mycophenolate sodium from mycophenolate mofetil in stable renal transplant patients: results of an Asia-Pacific study.

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJCP.12660

http://www.w3.org/2001/XMLSchema#string

P433

183

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26176848

http://www.w3.org/2001/XMLSchema#string